Tumor-associated microglia and macrophages in glioblastoma: From basic insights to therapeutic opportunities
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Immunology"
DOI: 10.3389/fimmu.2022.964898
Abstract: Glioblastoma (GBM) is the most common and malignant primary brain tumor in adults. Currently, the standard treatment of glioblastoma includes surgery, radiotherapy, and chemotherapy. Despite aggressive treatment, the median survival is only 15 months. GBM… read more here.
Keywords: associated microglia; glioblastoma basic; macrophages glioblastoma; microglia macrophages ... See more keywords